Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.72 and traded as high as $1.03. Mesoblast shares last traded at $1.03, with a volume of 100 shares.
Mesoblast Stock Up 15.6 %
The stock’s fifty day moving average price is $0.72 and its 200-day moving average price is $0.72.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- Options Trading – Understanding Strike Price
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Earnings Per Share Calculator: How to Calculate EPS
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
